Genesee Valley Trust’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Genesee Valley Trust's LLY Position: Q1 2018 in Review
Genesee Valley Trust increased its Eli Lilly (LLY) stake by 3.1% in Q1 2018, buying an estimated $7.25K and bringing the position to 3,033 shares worth $234K. The position accounts for 0.1% of the portfolio, ranked #182.
Genesee Valley Trust first reported a position in LLY in Q2 2013 and has held it in 19 quarters since. The position peaked at $458K in Q1 2015. 1,333 funds tracked by Wall St. Rank hold LLY as of Q1 2018.
- Genesee Valley Trust held 3,033 shares of Eli Lilly worth $234K as of Q1 2018.
- Genesee Valley Trust bought 90 Eli Lilly shares in Q1 2018, an estimated $7.25K.
- Eli Lilly made up 0.1% of Genesee Valley Trust's portfolio in Q1 2018, its #182 holding.
- Genesee Valley Trust first reported a position in Eli Lilly in Q2 2013 and has held it in 19 quarters since.
- Genesee Valley Trust's Eli Lilly position peaked at $458K in Q1 2015.
- 1,333 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2018.
Based on Genesee Valley Trust's 13F filing for Q1 2018, filed 3 Apr 2018.